English
简体中文
繁體中文
客服热线:400-1616-289
登录
注册
会议论文
Mutational profiling of newly diagnosed glioblastoma to identify predictive biomarkers of efficacy and safety of anlotinib combination therapy.
Lai, Shuzhen; Li, Peijing; Liu, Xiaohui; Liu, Guihong; Xie, Tieming; Zhang, Xing; Wang, Xiaoxuan; Huang, Jing; Tang, Yiqiang; Liu, Zhigang; Shen, Guoping; Li, Chaoming; Lu, Fangxiao; Wang, Lei; Jiang, Fagui; Sun, Caixing; Chen, Yuan Yuan Yuan
南昌大学; 南方医科大学; 汕头大学; 中山大学; 中国科学院研究生院; 1
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
2023-6-1
2
阅读
引用
收藏
分享
相关
加载中…
文献加载失败,请重试
重试